In January 2018, Congress acted on a bipartisan basis to temporarily suspend the medical device excise tax, the second consecutive two-year suspension of this tax. Legislation pending in Congress would repeal the tax once and for all. Bipartisan opposition to the medical device tax stems from its negative impact on research and development. Medical devices - diagnostics, joint replacements and other prosthetics, pacemakers, and more - play a crucial role in health and healthcare. It is time to end this tax, leveling the playing field for medical device R&D. Weigh in with your Congressional delegation now!
By submitting your information, you agree to receive email communications from Research!America. Manage your email communication preferences by clicking the "unsubscribe" link in an email.